Company profile: Instem
1.1 - Company Overview
Company description
- Provider of information solutions and scientific insight services for Life Sciences R&D, with software that accelerates drug and chemical development. Products include Provantis Suite for toxicology study management; BioRails for data workflows; Submit for creating SEND datasets and storing files with version control; Accel for cloud statistical computing; Morphit for instrument data to validated results; Blur for NLP-based anonymization.
Products and services
- BioRails: Engineers a workflow-driven laboratory data management system to organize and manage data in laboratories using defined workflows
- Provantis Suite: Produces software for managing toxicology studies, designed for both single users and global multi-site organizations
- Submit: Creates software for generating SEND datasets and storing files with version control to manage datasets and files
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Instem
Clinerion
HQ: Switzerland
Website
- Description: Provider of real-world data solutions analyzing live electronic health record data from a global network of partner hospitals to accelerate clinical research and access to treatments. Offerings include Patient Network Explorer for clinical research, trial optimization, and analytics; Feasibility Insights for site feasibility and trial planning; and RWD RADAR delivering aggregated de-identified data for epidemiology, treatment metrics, and market insights.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinerion company profile →
Nimble Therapeutics
HQ: United States
Website
- Description: Provider of a drug discovery platform that applies massively parallel, maskless chemical synthesis to synthesize and systematically discover novel medicines across a variety of therapeutic areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nimble Therapeutics company profile →
Teckro
HQ: United States
Website
- Description: Provider of mobile-first clinical research technology and services, including an app for real-time data capture and study interaction; site engagement assessment with reports and insights; a communications playbook; support for study enrollment and patient retention; and tools for protocol adherence with immediate access to current protocols and expert guidance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Teckro company profile →
4Tune Engineering
HQ: Portugal
Website
- Description: Provider of intelligent engineering solutions focused on operational excellence, helping companies decisively improve the entire life-cycle of their products and processes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 4Tune Engineering company profile →
Neem Biotech
HQ: United Kingdom
Website
- Description: Provider of biotechnology services specializing in pilot- to industrial-scale extraction of bio-active compounds from plant and marine sources to high-purity levels. Based in Cardiff, United Kingdom; incorporated in 1998 and, since July 20, 2012, operating as a subsidiary of InQpharm Group.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neem Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Instem
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Instem
2.2 - Growth funds investing in similar companies to Instem
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Instem
4.2 - Public trading comparable groups for Instem
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →